XRCC2 and colorectal carcinoma: Our previous studies have shown that XRCC2 functions as a resistance factor that protects CRC cells from radiation-induced DSBs and that XRCC2 levels may act as a valid predictive biomarker of radiosensitivity in LARC patients [22].